Evidence map›Paper›PMID 32381600›Full record

ArticleJournal of the American Society of Nephrology : JASN2020

ADCK4 Deficiency Destabilizes the Coenzyme Q Complex, Which Is Rescued by 2,4-Dihydroxybenzoic Acid Treatment.

Eugen Widmeier, Seyoung Yu, Anish Nag, Youn Wook Chung, Makiko Nakayama, Lucía Fernández-Del-Río, Hannah Hugo, David Schapiro, Florian Buerger, Won-Il Choi and 7 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. The efficacy of coenzyme QJournal of cellular and molecular medicine · 2022
    Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Bypass Treatments for Primary Coenzyme Q10 Deficiency: An Update.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Therapies for Mitochondrial Disease: Past, Present, and Future.Journal of inherited metabolic disease · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Mechanisms of podocyte injury in genetic kidney disease.Pediatric nephrology (Berlin, Germany) · 2025
    Review
  15. Genetics in Kidney Diseases.Advances in kidney disease and health · 2025
    Review
  16. Understanding coenzyme Q.Physiological reviews · 2024
    Review
  17. Article
  18. Urinary podocyte markers in diabetic kidney disease.Kidney research and clinical practice · 2024
    Article
  19. Review
  20. Biosynthesis, Deficiency, and Supplementation of Coenzyme Q.Antioxidants (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Eugen WidmeierDivision of Nephrology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-7773-5190
Seyoung YuDepartments of Pharmacology, Yonsei University College of Medicine, Seoul, Korea hygee@yuhs.ac friedhelm.hildebrandt@childrens.harvard.edu.
Anish NagDepartment of Chemistry and Biochemistry, Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California.
Youn Wook ChungSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0002-4382-1410
Makiko NakayamaDivision of Nephrology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Lucía Fernández-Del-RíoDepartment of Chemistry and Biochemistry, Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California.
Hannah HugoDivision of Nephrology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
David SchapiroDivision of Nephrology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Florian BuergerDivision of Nephrology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Won-Il ChoiDivision of Nephrology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Martin HelmstädterRenal Division, Department of Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Jae-Woo KimBrain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Ji-Hwan RyuBrain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0001-6969-7465
Min Goo LeeDepartments of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.
Catherine F ClarkeDepartment of Chemistry and Biochemistry, Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California.
Friedhelm HildebrandtDivision of Nephrology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts hygee@yuhs.ac friedhelm.hildebrandt@childrens.harvard.edu.
Heon Yung GeeDepartments of Pharmacology, Yonsei University College of Medicine, Seoul, Korea hygee@yuhs.ac friedhelm.hildebrandt@childrens.harvard.edu.ORCID 0000-0002-8741-6177
Boston Children's Hospital · USYonsei University · KRUniversity of California, Los Angeles · USUniversity of Freiburg · DE

Funding

UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
Identification and function of new genes causing childhood nephrotic syndromeR01DK076683 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HILDEBRANDT, FRIEDHELM · 2007 to 2021
$5.3M
NIDDK NIH HHS P30 DK079337NIDDK NIH HHS R01 DK076683
6 · The paper itself

Abstract

backgroundMutations in

methodsTo elucidate the ADCK4's function in podocytes, we generated a podocyte-specific,

resultsAbsence of

conclusionsOur study shows that ADCK4 is required for CoQ

Indexed as

AnimalsEnzyme StabilityGlomerulosclerosis, Focal SegmentalHEK293 CellsHumansHydroxybenzoatesMethyltransferasesMiceMice, Inbred C57BLMitochondriaMitochondrial ProteinsPodocytesProtein KinasesUbiquinonebeta-resorcylic acidcoenzyme Q10COQ5 protein, humanCOQ8B protein, humanHydroxybenzoatesMethyltransferasesMitochondrial ProteinsProtein KinasesUbiquinone2,4-dihydroxybenzoic acidADCK4coenzyme Q10Q complexsteroid-resistant nephrotic syndrome

Identifiers

PMID32381600
PMCPMC7269352
OpenAlexW3021810682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.